Pulse power: beans and lentils may reshape your gut bacteria
NCT ID NCT07043712
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how eating a diet rich in pulses—like beans, lentils, and peas—affects the gut microbiome, feelings of fullness, and appetite hormones. Researchers are enrolling 44 overweight or obese adults who will follow a high-pulse diet for four weeks. The goal is to see if these foods can positively change gut bacteria and help with appetite control, which could be useful for managing metabolic syndrome.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- high pulse diet (beans, lentils, peas, chickpeas)
- What this could lead to
- If successful, this could show that eating more pulses helps improve gut health and appetite control, pointing toward dietary strategies for managing metabolic syndrome.
- What could go wrong
- This is a small, early-stage dietary study with only 44 participants. Results may not apply to everyone, and the diet may be hard to follow long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 44 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Men and women (premenopausal only) * Age 20-55y (we will attempt to start baseline testing at the same time of the menstrual cycle (luteal) for the women * BMI ≥25 or ≤40 kg/m2 (most at risk for metabolic abnormalities and will benefit from a pulse intervention-2/3 of Americans are overweight or obese) * Weight stable (no fluctuations in body weight of greater than 4 kg in the last 3 months) * Willing to consume a research diet * Willing to provide blood and fecal samples * Sedentary to low active physical activity status (less than 7200 steps per day) * Stably treated with statin drugs, anti-hypertensives, and anti-depressants. These are acceptable as long as the drug category does not alter appetite, body weight, or the microbiome (if known) * Pre-diabetes acceptable (glucose \<125 mg/dL or HbA1c \< 6.5%) * At least one characteristic of the metabolic syndrome (but not diabetic) 1. A large waistline: 35 inches or more for women 40 inches or more for men 2. High triglycerides: 150 mg/dL or higher 3. Low HDLc level: \<50 mg/dL for women \<40 mg/dL for men 4. High blood pressure ≥130/85 mmHg 5. Fasting blood sugar ≥100 mg/dL - Pre-diabetes acceptable (glucose \<125 mg/dL or HbA1c \<6.5%) - Exclusion Criteria: * Pregnant or lactating * Postmenopausal (evidence suggests an interplay between the gut microbiome) * BMI of \<25 or \>40 kg/m2 * Use of medications that affect the gut microbiome (e.g. antibiotics) * Taking medications known to affect appetite (e.g., phentermine) or gastrointestinal function (e.g., metformin) * On a special diet or undergoing weight loss, vegetarian, or other restricted dietary patterns * Ad libitum intake of fiber above 25g/day (mean intake in the US population is 17g/day) and \< 10g/d * History of disease (example colon cancer, HIV, cardiovascular disease, psychiatric disorders, etc.) * Use of tobacco products
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Missouri
Columbia, Missouri, 65212, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which exercise dose best helps kids with metabolic syndrome?
- Can a weekly weight drug quiet gout attacks?
- Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
- DNA sequencing could reveal hidden bacteria in burn wounds
- Ketogenic diet vs mediterranean diet: which better reshapes metabolism?
- Can tailoring bypass length improve weight loss surgery results?